0
2019
Top 10 Cancer Drugs Market

Top 10 Cancer Drugs Market

by Region (Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2018-2026
Update Available On-Demand

Report Code: A05860
Pages: 189
Nov 2019 | 5988 Views
Author(s) : Sayali Shinde , Onkar Sumant
Tables: 70
Charts: 78
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Top 10 Cancer Drugs Market

Request Now !

Top 10 Cancer Drugs Market Outlook - 2026

The global top 10 cancer drugs market sales was valued at $63,619 million in 2018 and is expected to reach $129,948 million by 2026, registering a CAGR of 9.8% from 2019 to 2026.

Cancer is medical condition in which abnormal cells grow with the potential to invade or spread to other parts of the body. Different forms of the drugs used for the treatment of cancer majorly include, chemotherapy, targeted therapy, immunotherapy (biologic therapy), and others. It is estimated that cancer drugs market show significant market growth during the forecast period owing to increase in prevalence of various forms of cancer, surge in popularity of advance therapies such as biological & targeted drug therapies, development in screening procedures and rise in geriatric population worldwide, increase in R&D activities, and availability of cancer drugs are expected to boost the top 10 cancer drugs market growth. 

Top 10 Cancer Drugs Market

Top 10 Cancer Drugs Market Segmentation  

The top 10 cancer drugs market size is analyzed across Europe (Germany, UK, Italy, Spain, France, Czech Republic, Republic of Moldova, Poland, Hungary, Romania, Russia, Slovakia, Ukraine, Greece, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Qatar, Lebanon, Jordan, and rest of LAMEA). 

By Region

Europe is the second largest market for cancer therapeutics after North America owing to the strong presence of pharmaceutical companies in Europe that specialize in oncology drug development. Some of these companies include Roche, Novartis International AG, AstraZeneca, and others. The prevalence of cancer in Europe has increased significantly in the past few years. According to the World Health Organization (WHO, 2018), currently, more than three million cancer cases are registered every year in Europe. Moreover, factors such as high prevalence of cancer, increase in demand for effective medicines, high disposable income, and rise in disease awareness due to public & private initiatives drive the growth of the cancer therapeutics market in Europe. In addition, surge in geriatric population across the region boosts the market growth. However, Asia-Pacific is expected to exhibit fastest growth rate in the near future, owing to surge in awareness related advanced drug therapy. The other factors that boost the growth of the market include presence of huge patient base suffering and rise in healthcare expenditure in the region. Furthermore, the constantly evolving life science industry is anticipated to offer lucrative opportunities for market expansion in the developing economies such as India, China, and Malaysia. 

Major players operating in the market include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG, and Pfizer Inc. 

Key Benefits for Top 10 Cancer Drugs Market:

  • This report entails a detailed quantitative analysis along with the current Top 10 cancer drugs market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.
  • The top 10 cancer drugs market forecast is studied from 2019 to 2026. 
  • The market size and estimations are based on a comprehensive analysis of key developments in the Top 10 cancer drugs industry. 
  • A qualitative analysis based on innovative products facilitates strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the top 10 cancer drugs market.

Top 10 Cancer Drugs Market Segments:

By Region

Europe

  • Russia
  • Netherlands
  • Switzerland
  • Sweden
  • Belgium
  • Austria
  • Norway
  • Denmark
  • Poland
  • Finland
  • Portugal
  • Greece
  • Ireland
  • Czech Republic
  • Hungary
  • Romania
  • Ukraine

Asia-Pacific

  • Taiwan
  • Indonesia
  • New Zealand
  • Singapore
  • Malaysia
  • Vietnam
  • Myanmar
  • Sri Lanka
  • Macau
  • Nepal

LAMEA

  • Turkey
  • Venezuela
  • Colombia
  • Argentina
  • Iran
  • Israel
  • Chile
  • Algeria
  • United Arab Emirates
  • Puerto Rico
  • Morocco
  • Costa Rica
  • Lebanon

Top 10 Cancer Drugs Market Report Highlights

Aspects Details
By Region
  • Europe  (Russia, Netherlands, Switzerland, Sweden, Belgium, Austria, Norway, Denmark, Poland, Finland, Portugal, Greece, Ireland, Czech Republic, Hungary, Romania, Ukraine)
  • Asia-Pacific  (Taiwan, Indonesia, New Zealand, Singapore, Malaysia, Vietnam, Myanmar, Sri Lanka, Macau, Nepal)
  • LAMEA  (Turkey, Venezuela, Colombia, Argentina, Iran, Israel, Chile, Algeria, UAE, Puerto Rico, Morocco, Costa Rica, Lebanon)
Key Market Players ABBVIE INC, ASTELLAS PHARMA INC, ASTRAZENECA PLC, BRISTOL-MYERS SQUIBB COMPANY, CELGENE CORPORATION, F. HOFFMANN-LA ROCHE LTD, JOHNSON & JOHNSON (JANSSEN GLOBAL SERVICES, LLC,), MERCK & CO., INC, NOVARTIS AG, PFIZER INC
 

Loading Table Of Content...


 
 

Cancer is medical condition in which abnormal cells grow with the potential to invade or spread to other parts of the body. The cancer drugs market is anticipated to show significant market growth during the forecast period owing to increase in prevalence of various forms of cancer, surge in popularity of advance therapies such as biological & targeted drug therapies, development in screening procedures, and rise in geriatric population worldwide. In addition, increase in R&D activities, and availability of cancer drugs are expected to boost the market growth. High potential of emerging economies and increase in number of pipeline products are expected to provide new opportunities for market players in future. On the other side, high cost involved in new drug development and adverse effects associated with cancer drugs therapies is expected to restrain the growth of the market. 

In the current scope of the study, Europe accounted for the highest market share in 2018, due to availability of cancer drugs, strong presence of key players, higher adoption of advanced therapeutics, and favorable reimbursement policies in healthcare system, followed by Asia-Pacific. In addition, pharmaceutical companies have focused on expanding their presence in emerging economies, and rise in incidence of different forms of cancer anticipated to drive the market growth in Asia-Pacific.  

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Request Free Sample
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Free Sample

OR

Purchase Full Report of
Top 10 Cancer Drugs Market

Start reading instantly.
This Report and over 18,777+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
    (Nov 2020 - Nov 2021)
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2020 - Nov 2021)
  • Single User
  • $5,769
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2020 - Nov 2021)
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2020 - Nov 2021)
  • Enterprise
    License/PDF

  • $10,995
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
    (Nov 2020 - Nov 2021)
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers